COVID-19 set back Alzheimer’s disease research
AuntMinnie
FEBRUARY 5, 2024
Alzheimer’s disease (AD) research centers saw a 77% drop in participants enrolling in clinical trials due to the COVID-19 pandemic, according to a study conducted by epidemiologists at the University of Pittsburgh. Few recruitment approaches have been directly tested via intervention trials at Alzheimer’s disease centers, they added.
Let's personalize your content